ginkgolide a has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, D; Li, P; Li, Y; Mao, Y; Wu, X; Yong, Y; Zhao, K; Zhou, Z | 1 |
| Wu, X; Wu, Z; Ye, F; You, W | 1 |
2 other study(ies) available for ginkgolide a and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Fibronectins; Fibrosis; Ginkgolides; Heart Diseases; Inflammation; Lactones; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocytes, Cardiac; Rats; Ventricular Remodeling | 2022 |
Ginkgolide A protects adverse cardiac remodeling through enhancing antioxidation and nitric oxide utilization in mice with pressure overload.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Ginkgolides; Lactones; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Signal Transduction; Ventricular Remodeling | 2019 |